Division of Vascular Surgery, Peter Munk Cardiac Centre & University Health Network, University of Toronto, Toronto, Ontario, Canada.
Division of Vascular Surgery, Peter Munk Cardiac Centre & University Health Network, University of Toronto, Toronto, Ontario, Canada.
Ann Vasc Surg. 2022 May;82:131-143. doi: 10.1016/j.avsg.2021.10.068. Epub 2021 Dec 10.
Previous studies have demonstrated important geographic variations in peripheral artery disease (PAD) management despite existing guidelines. We assessed differences in patient characteristics, procedural technique, and outcomes for PAD interventions in Canada versus United States.
The Vascular Quality Initiative (VQI) was used to identify all patients who underwent endovascular intervention or surgical bypass for PAD between 2010 and 2019 in Canada and United States. Independent t-test and chi-square test were performed to assess differences between countries in terms of demographic, clinical, and procedural characteristics. The primary outcome was the percentage of interventions performed for claudication versus chronic limb-threatening ischemia (CLTI). Perioperative outcomes were in-hospital mortality and index limb amputation. The long-term outcome was 1-year amputation-free survival. Univariate/multivariate logistic regression and Cox proportional hazards analysis were performed to investigate associations between region and outcomes.
A total of 246,770 US patients and 3,467 Canadian patients underwent revascularization for PAD during the study period. There was a higher proportion of endovascular interventions in the US (75.9% vs. 69.2%, OR 1.41 [95% CI 1.31-1.51], P< 0.001). American patients were younger with more comorbidities, including hypertension, diabetes, and coronary artery disease. The percentage of interventions performed for claudication was significantly higher in the US (42.3% vs. 35.7%, OR 1.31 [95% CI 1.22-1.44], P< 0.001). This persisted after controlling for demographic, clinical, and procedural characteristics (adjusted OR 1.05 [95% CI 1.01-1.10], P = 0.02). Perioperative outcomes were similar between countries after adjustment for baseline differences: in-hospital mortality (adjusted OR 1.07 [95% CI 0.69-1.62], P= 0.75) and index limb amputation (adjusted OR 0.67 [95% CI 0.43-1.07], P= 0.09). However, 1-year amputation-free survival was higher in the US (84.1% vs. 71.0%, HR 1.61 [95% CI 1.47-1.76], P< 0.001). Multivariable Cox proportional hazards analysis demonstrated that the factor most strongly associated with index limb amputation or death at 1-year was intervention for CLTI (HR 1.56 [95% CI 1.54-1.58], P< 0.001).
There are significant variations in PAD management between US and Canada. In particular, a higher proportion of interventions are performed for claudication rather than CLTI in the US compared to Canada. This is an important contributor to the higher 1-year amputation-free survival rate in US patients. Reasons for these differences should be assessed by future studies and evidence-based care may be standardized by targeted quality improvement projects.
尽管存在指南,但先前的研究表明,周围动脉疾病(PAD)的管理存在重要的地域差异。我们评估了加拿大和美国 PAD 介入治疗在患者特征、手术技术和结果方面的差异。
利用血管质量倡议(VQI),我们在加拿大和美国识别了 2010 年至 2019 年间接受过 PAD 血管内介入或旁路手术的所有患者。采用独立 t 检验和卡方检验,评估两国之间在人口统计学、临床和手术特征方面的差异。主要结果是为间歇性跛行与慢性肢体威胁性缺血(CLTI)进行的干预比例。围手术期结果为院内死亡率和索引肢体截肢。长期结果为 1 年无截肢生存率。进行单变量/多变量逻辑回归和 Cox 比例风险分析,以研究区域与结果之间的关系。
在研究期间,共有 246770 名美国患者和 3467 名加拿大患者接受了 PAD 血运重建。美国的血管内介入治疗比例更高(75.9% vs. 69.2%,OR 1.41 [95%CI 1.31-1.51],P<0.001)。美国患者更年轻,合并症更多,包括高血压、糖尿病和冠状动脉疾病。美国为间歇性跛行进行的干预比例明显更高(42.3% vs. 35.7%,OR 1.31 [95%CI 1.22-1.44],P<0.001)。在控制人口统计学、临床和手术特征后,这一趋势仍然存在(调整后的 OR 1.05 [95%CI 1.01-1.10],P=0.02)。在调整基线差异后,两国的围手术期结果相似:院内死亡率(调整后的 OR 1.07 [95%CI 0.69-1.62],P=0.75)和索引肢体截肢(调整后的 OR 0.67 [95%CI 0.43-1.07],P=0.09)。然而,美国的 1 年无截肢生存率更高(84.1% vs. 71.0%,HR 1.61 [95%CI 1.47-1.76],P<0.001)。多变量 Cox 比例风险分析表明,与 1 年索引肢体截肢或死亡最相关的因素是 CLTI 的干预(HR 1.56 [95%CI 1.54-1.58],P<0.001)。
美国和加拿大之间在 PAD 管理方面存在显著差异。特别是,与加拿大相比,美国为间歇性跛行进行的干预比例更高,而非 CLTI。这是美国患者 1 年无截肢生存率较高的一个重要原因。未来的研究应该评估这些差异的原因,并通过有针对性的质量改进项目使循证护理标准化。